Free Trial

Intelligent Ultrasound Group (IUG) Competitors

Intelligent Ultrasound Group logo
GBX 12.58 +0.01 (+0.04%)
(As of 12/20/2024 12:31 PM ET)

IUG vs. EKF, CREO, NCYT, BELL, POLX, IHC, AVO, RUA, MHC, and SUN

Should you be buying Intelligent Ultrasound Group stock or one of its competitors? The main competitors of Intelligent Ultrasound Group include EKF Diagnostics (EKF), Creo Medical Group (CREO), Novacyt (NCYT), Belluscura (BELL), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), MyHealthChecked (MHC), and Surgical Innovations Group (SUN). These companies are all part of the "medical devices" industry.

Intelligent Ultrasound Group vs.

EKF Diagnostics (LON:EKF) and Intelligent Ultrasound Group (LON:IUG) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability, community ranking and analyst recommendations.

EKF Diagnostics has higher revenue and earnings than Intelligent Ultrasound Group. Intelligent Ultrasound Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EKF Diagnostics£50.95M2.37£4.78M£0.012,660.00
Intelligent Ultrasound Group£9.88M4.16-£3.43M-£0.01-1,258.00

70.3% of EKF Diagnostics shares are owned by institutional investors. Comparatively, 75.5% of Intelligent Ultrasound Group shares are owned by institutional investors. 5.2% of EKF Diagnostics shares are owned by company insiders. Comparatively, 12.8% of Intelligent Ultrasound Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

EKF Diagnostics has a net margin of 9.37% compared to Intelligent Ultrasound Group's net margin of -33.78%. EKF Diagnostics' return on equity of 7.58% beat Intelligent Ultrasound Group's return on equity.

Company Net Margins Return on Equity Return on Assets
EKF Diagnostics9.37% 7.58% 5.27%
Intelligent Ultrasound Group -33.78%-36.19%-13.51%

EKF Diagnostics received 327 more outperform votes than Intelligent Ultrasound Group when rated by MarketBeat users.

CompanyUnderperformOutperform
EKF DiagnosticsOutperform Votes
327
76.76%
Underperform Votes
99
23.24%
Intelligent Ultrasound GroupN/AN/A

In the previous week, EKF Diagnostics had 2 more articles in the media than Intelligent Ultrasound Group. MarketBeat recorded 2 mentions for EKF Diagnostics and 0 mentions for Intelligent Ultrasound Group. Intelligent Ultrasound Group's average media sentiment score of 0.64 beat EKF Diagnostics' score of 0.00 indicating that Intelligent Ultrasound Group is being referred to more favorably in the news media.

Company Overall Sentiment
EKF Diagnostics Neutral
Intelligent Ultrasound Group Positive

EKF Diagnostics has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, Intelligent Ultrasound Group has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500.

Summary

EKF Diagnostics beats Intelligent Ultrasound Group on 10 of the 14 factors compared between the two stocks.

Get Intelligent Ultrasound Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for IUG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IUG vs. The Competition

MetricIntelligent Ultrasound GroupMedical Devices IndustryMedical SectorLON Exchange
Market Cap£41.14M£2.25B£5.12B£1.69B
Dividend YieldN/A2.37%4.91%11.86%
P/E Ratio-1,258.00214.9991.341,664.81
Price / Sales4.16200.841,116.59347,854.21
Price / Cash7.1515.3842.6438.18
Price / Book6.294.214.792.82
Net Income-£3.43M£77.46M£120.07M£149.84M
7 Day Performance15.68%-0.15%-1.89%-1.79%
1 Month Performance8.92%12.04%11.45%15.93%
1 Year Performance34.55%10.28%30.61%26.94%

Intelligent Ultrasound Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IUG
Intelligent Ultrasound Group
N/AGBX 12.58
+0.0%
N/A+31.0%£41.14M£9.88M-1,258.0065News Coverage
High Trading Volume
EKF
EKF Diagnostics
N/AGBX 25.30
-2.7%
N/A-10.1%£114.79M£50.95M2,530.00356News Coverage
Gap Up
CREO
Creo Medical Group
N/AGBX 18
+2.9%
N/A-46.6%£65.12M£30.30M-291.67279News Coverage
Positive News
NCYT
Novacyt
N/AGBX 52.06
+0.5%
N/A-18.7%£36.77M£18.56M-99.62120
BELL
Belluscura
N/AGBX 10
flat
N/A-56.4%£16.84M£1.80M-100.0024Gap Up
POLX
Polarean Imaging
N/AGBX 1.29
-4.4%
N/A-80.1%£15.61M£1.87M-67.5028
IHC
Inspiration Healthcare Group
N/AGBX 12.65
-0.8%
N/A-66.1%£11.34M£34.30M-91.07224Gap Down
AVO
Advanced Oncotherapy
N/AGBX 1.75
-9.1%
N/A+0.0%£9.50MN/A-25.003,900Gap Down
RUA
RUA Life Sciences
N/AGBX 11
+3.6%
N/A+7.9%£6.83M£2.19M-275.0048
MHC
MyHealthChecked
N/AGBX 11.25
+2.3%
N/A+8.4%£5.85M£9.39M-562.5016Gap Down
SUN
Surgical Innovations Group
N/AGBX 0.55
-0.9%
N/A-11.5%£5.13M£12.54M-21.1180News Coverage

Related Companies and Tools


This page (LON:IUG) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners